Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Interleukin-18 (IL-18) antagonists

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Interleukin-18 (IL-18) is considered a potential target for intervention. However no specific Interleukin-18 (IL-18) antagonists have been identified for clinical use
Jefferis et al. 2011 Atherosclerosis 217(1): 227-33
O'Brien et al. 2014 Mol Med. 20(1): 221-9
…

References (Sources)

Interleukin 18 and coronary heart disease: prospective study and systematic review
Jefferis et al. 2011 Atherosclerosis 217(1): 227-33
Review
Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure
O'Brien et al. 2014 Mol Med. 20(1): 221-9

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Interleukin-18 (IL-18) antagonists

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat